mProve ziekenhuizen

What mProve ziekenhuizen does

mProve ziekenhuizen is a Dutch cooperative network of seven top clinical (topklinische) hospitals — Albert Schweitzer ziekenhuis, Isala, Jeroen Bosch Ziekenhuis, Máxima MC, Noordwest Ziekenhuisgroep, Rijnstate, and Zuyderland Medisch Centrum — collaborating on healthcare innovation across approximately 18% of Dutch hospital care. Founded in 2017 and headquartered in Dordrecht, mProve operates three thematic programs: Passende Zorg (appropriate care), Arbeidsbesparende Technologie (labor-saving technology, executed via the Funxlab program), and Datagedreven Werken (data-driven working, executed via the mPlify platform). The network collectively employs 35,000+ healthcare professionals and delivers roughly 5 million outpatient appointments annually.

The portfolio is anchored by mPlify, an internal data platform aggregating patient data from all seven hospitals for benchmarking and predictive analytics, and includes clinical and operational products such as AI in de Spreekkamer (ambient AI documentation), AI voor Protocollen (natural-language search over Zenya protocols), Virtual Fracture Care, CVA eCoach, No Show prediction, Robotic Process Automation, BoneView AI radiology, and standardized care pathways for osteoarthritis, atrial fibrillation, pelvic floor disorders, and breast cancer follow-up. mProverij is the monthly knowledge-sharing forum spreading innovations across member hospitals, and artrose.org is a national patient-facing platform. Partnerships span CumuluZ (data integration), Amsterdam UMC and University of Twente (research), Santeon and NOV (orthopedic standards), SPIRIT consortium, and ZonMw/VWS (research subsidies).

The business model is institutional rather than commercial: mProve receives transformation funding through the Integraal Zorg Akkoord (IZA) from health insurers VGZ and Zilveren Kruis (€12.9 million approved for the first project series), supplemented by research grants (e.g., €350,000 from ZonMw for Early Warning Scores research) and member-hospital contributions. Patient-facing revenue flows to the individual member hospitals through standard Dutch basisverzekering reimbursement; mProve itself does not publicly disclose standalone revenue. Governance is composed of the board chairs and staff chairs of the seven member hospitals, with rotating chairmanship; leadership transitioned in 2025–2026 with Nicole Stolk assuming the chair and Hugo Solleveld appointed director effective 1 February 2026.

Name

mProve ziekenhuizen

Legal name

mProve

Website

https://mprove.nu

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

mProve ziekenhuizen is a Dutch cooperative network of seven top clinical hospitals delivering roughly 18% of Dutch hospital care and collaborating on healthcare innovation, data analytics (mPlify), labor-saving technology (Funxlab), and standardized care pathways funded through IZA transformation agreements.

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

akta.pro secondary industries

Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)

Keywords

• Hospital collaboration network
• Healthcare innovation programs
• Data-driven healthcare
• Value-based care
• Labor-saving technology

Headquarters

HQ city

Dordrecht

HQ country

Netherlands

HQ region

Europe

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Service Delivery: mProve's seven member hospitals provide medical services to patients, funded through standard Dutch healthcare insurance reimbursement (basisverzekering). Revenue comes from treating patients covered by Dutch health insurers.
2. Healthcare Transformation Funding (IZA): mProve receives 12.9 million euros in transformation funds from the Integraal Zorg Akkoord (IZA) for implementing transformation projects focused on labor-saving technology and appropriate care. Funding is conditional on achieving defined objectives.
3. Research Grants and Subsidies: mProve hospitals receive research funding from organizations such as ZonMw (350,000 EUR for Early Warning Scores research) and VWS ministry (for CumuluZ data infrastructure).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

mProve is a collaborative network of seven top clinical hospitals in the Netherlands that jointly develop, pilot, and scale healthcare innovations across three themes: Passende Zorg (appropriate care), Arbeidsbesparende Technologie (labor-saving technology), and Datagedreven Werken (data-driven working). It delivers shared programs in AI-powered consultation documentation, home medication administration, virtual fracture care, stroke digital coaching, predictive no-show modeling, and a unified data platform (mPlify) that enables cross-hospital benchmarking and value-based care pathways.

Product overview

mProve ziekenhuizen is a collaborative network of seven top clinical hospitals in the Netherlands operating as a unified platform for healthcare transformation. The portfolio consists of mPlify as the foundational data platform powering all data-driven initiatives, supported by Funxlab for labor-saving technology innovation and mProverij for cross-hospital knowledge sharing. Key clinical programs include AI in de Spreekkamer (AI-powered speech recognition for consultation documentation), Medicatie@home (home-based medication administration), AI voor Protocollen (natural language protocol search), Virtual Fracture Care (hybrid fracture care via app), CVA eCoach (stroke patient digital coaching), No Show prediction, and multiple value-based care pathways for conditions including osteoarthritis, atrial fibrillation, pelvic floor disorders, and breast cancer follow-up. The network enables hospitals to share learning, benchmark performance, and scale proven innovations across all member institutions.

Differentiator

Problem solved

Functional benefit

Brands

• mPlify: Data platform of the seven mProve hospitals that collects, processes, and analyzes patient data securely to support data-driven healthcare improvement and benchmarking.
• Funxlab
• mProverij

Products and services

• mProve Zorgvernieuwingsnetwerk (Hospital Innovation Network)

Quantifiable outcome

• 50% reduction in outpatient checkups for stroke patients using CVA eCoach
• +5 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability16 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Stichting CumuluZ ZorgdatacoreStrategic or Co-development Partner · 12 March 2025CumuluZ develops a data integration functionality that retrieves and standardizes medical data from various systems. mProve contributes actively to testing and refining CumuluZ functionality in practice. The Dutch Ministry of VWS provides funding to CumuluZ for improving health data availability for patients, providers, and researchers.
• University of Twente (UT Twente)coreStrategic or Co-development PartnerCollaboration with UT Twente on Medicatie@home project to determine KPIs for implementation and evaluate organizational models for home medication administration. Researcher Jedidja Lok-Visser from UT Twente and Isala developed quality indicator set for home parenteral medication.
• ReumaNederlandminorStrategic or Co-development PartnerCollaboration with ReumaNederland and regional care partners (GPs, physiotherapists) to build regional arthritis networks and consistent information. Jointly developing patient information website artrose.org.
• Nederlandse Orthopaedische Vereniging (NOV)coreStrategic or Co-development PartnerCollaboration with NOV and Traumachirurgie NL on Virtual Fracture Care (VFC) for developing uniform, hybrid care pathways for patients with broken ankles. NOV supports standards and guidelines for orthopedic care.
• Traumachirurgie NLcoreStrategic or Co-development PartnerCollaboration with Traumachirurgie NL and NOV on Virtual Fracture Care (VFC) hybrid care pathways for trauma patients.
• SanteoncoreStrategic or Co-development PartnerCollaboration with Santeon hospitals on Virtual Fracture Care (VFC) for broken ankle patients. Santeon network shares expertise and implementation experience for standardized trauma care.
• PharosminorStrategic or Co-development PartnerPharos experts on 'digital care for everyone' collaborated on webinars about low health literacy and digital communication. Experts Chandra Verstappen and Sevde Koca provided guidance on making digital healthcare accessible.
• Amsterdam UMCminorStrategic or Co-development PartnerAmsterdam UMC's Department of Epidemiology and Data Science provides supplementary methodological expertise for Early Warning Scores (EWS) research project conducted by four mProve hospitals.
• SPIRIT ConsortiumminorStrategic or Co-development PartnermProve is a practical partner in SPIRIT - Technology for Sustainable Care, a national research program where 50+ partners cooperate on technological and social innovations to keep healthcare human. Kick-off held for collaborative research initiatives.
• ACP-coalitieminorStrategic or Co-development PartnermProve plays a connecting and pioneering role in the ACP-coalition bringing together regional and national initiatives to accelerate appropriate care through advance care planning. Partners include Regioplatform, RSO Zorgring, Medisch Spectrum Twente, RSO Zuid-Limburg, Nictiz, and IKNL.
• Nederlandse Vereniging voor Gynaecologie en Obstetrie (NVOG)minorStrategic or Co-development PartnerGuidelines from NVOG inform the approach for Total Laparoscopic Hysterectomy (TLH) in day treatment for Heavy Menstrual Bleeding. The NVOG provides clinical standards for gynecological procedures.
• Huisartsen (General Practitioners)minorChannel Partner/ Reseller/ DistributorRegional GPs are key partners in care pathways such as pelvic floor care (pessarium referral), arthritis care, and home medication administration. They receive support for stepped care approaches.
• Nederlandse Zorgautoriteit (NZa)coreOthersNZa established a care product description (facultatieve prestatie) for the pessarium care pathway, enabling hospitals to make tariff agreements with health insurers and declar the pathway structurally.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Karolinska University Hospital: Swedish academic hospital system with a strong focus on digital health, AI deployment, and outcomes research. Comparable to mProve as a Northern European publicly-funded hospital network driving healthcare innovation.

Broad incumbents

• Mayo Clinic: Large integrated US health system operating multiple hospital campuses with a strong focus on data-driven care, clinical innovation, and outcomes measurement. Comparable to mProve as a multi-hospital network using data and AI to standardize care.
• Cleveland Clinic: US multi-hospital health system with strong focus on clinical outcomes, AI-enabled diagnostics, and digital health innovation. Comparable to mProve in deploying AI tools and standardized care pathways across multiple sites.
• Kaiser Permanente: US integrated payer-provider system combining insurance, hospitals, and physician groups with extensive use of EHR data and value-based care. Comparable to mProve as a coordinated network leveraging data and capitated funding to drive transformation.
• Mass General Brigham: US academic health system operating multiple hospitals with extensive research infrastructure and digital health initiatives. Comparable to mProve's combination of top clinical care and joint research programs (e.g., EWS research with Amsterdam UMC).
• Intermountain Healthcare: US non-profit health system operating multiple hospitals with a long-standing focus on data analytics, value-based care, and standardized clinical pathways. Comparable to mProve's mPlify data platform and care pathway work.
• Geisinger Health: US integrated health system known for pioneering value-based care models, EHR-driven innovation, and population health analytics. Comparable to mProve's data-driven care coordination approach.

Others

• ICHOM (International Consortium for Health Outcomes Measurement): Non-profit consortium that defines standard sets for measuring patient outcomes, used by mProve in its osteoarthritis value-based healthcare initiative. Comparable as an ecosystem enabler for value-based care rather than a direct competitor.
• STZ (Samenwerkende Topklinische opleidingsZiekenhuizen): Association of Dutch top clinical teaching hospitals of which all seven mProve member hospitals are members. STZ provides the governance umbrella and innovation framework (including the STZ Innovatieprijs that mProve won in 2022) under which mProve operates.

Direct peers

• Santeon: Collaboration of seven Dutch top clinical hospitals focused on value-based healthcare improvement through shared learning and outcome measurement. Direct comparable to mProve's network model, and explicitly collaborates with mProve on Virtual Fracture Care and other pathways.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mprove-ziekenhuizen

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about mProve ziekenhuizen